The State of Cancer Care in the United Arab Emirates in 2022

Cancer is the third-leading cause of death in the United Arab Emirates (UAE); cancer care in the UAE has evolved dramatically over the last 40 years, from a single center in Al Ain in 1981 to more than 30 cancer centers and clinics across the UAE, with at least four comprehensive cancer centers in t...

Full description

Bibliographic Details
Main Author: Humaid O. Al-Shamsi
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Clinics and Practice
Subjects:
Online Access:https://www.mdpi.com/2039-7283/12/6/101
_version_ 1797460845479854080
author Humaid O. Al-Shamsi
author_facet Humaid O. Al-Shamsi
author_sort Humaid O. Al-Shamsi
collection DOAJ
description Cancer is the third-leading cause of death in the United Arab Emirates (UAE); cancer care in the UAE has evolved dramatically over the last 40 years, from a single center in Al Ain in 1981 to more than 30 cancer centers and clinics across the UAE, with at least four comprehensive cancer centers in the UAE nowadays. Despite the significant progress in medical care, cancer quality control across the UAE is still lacking, with significant variations in cancer care across the cancer centers. Access to clinical trials is still hampered by a lack of expertise and research infrastructure and a small population, which renders patient accrual for trials a major challenge. Education and training are other areas for improvement that require immediate attention, and, in this review, we try to address these critical aspects for stakeholders to consider better cancer care in the UAE. Early cancer detection and screening are still evolving in the UAE, and a national screening program is lacking. There is also a need to address barriers to screening and to consider less invasive screening methods such as approved blood-based screening, which is likely to be more acceptable to the UAE population. In this review, we also address new topics that have not been addressed previously, including oncology medical tourism, psycho-oncology, onco-fertility, precision oncology, survivorship, oncology nursing, cancer support programs, and the oncology sector’s response to the COVID-19 pandemic, all in the context of the UAE cancer landscape. Finally, we provide recommendations for policymakers, regulators, payers, patient advocacy groups, and the UAE oncology community regarding the delivery and future planning of high-quality cancer care. These recommendations are aligned with the UAE government’s vision to reduce cancer mortality and provide high-quality healthcare for its citizens and residents.
first_indexed 2024-03-09T17:10:52Z
format Article
id doaj.art-f6dcf57a7d054c1fbfc529f8f6ef46e9
institution Directory Open Access Journal
issn 2039-7283
language English
last_indexed 2024-03-09T17:10:52Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Clinics and Practice
spelling doaj.art-f6dcf57a7d054c1fbfc529f8f6ef46e92023-11-24T14:05:17ZengMDPI AGClinics and Practice2039-72832022-11-0112695598510.3390/clinpract12060101The State of Cancer Care in the United Arab Emirates in 2022Humaid O. Al-Shamsi0Department of Oncology, Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi P.O. Box 92510, United Arab EmiratesCancer is the third-leading cause of death in the United Arab Emirates (UAE); cancer care in the UAE has evolved dramatically over the last 40 years, from a single center in Al Ain in 1981 to more than 30 cancer centers and clinics across the UAE, with at least four comprehensive cancer centers in the UAE nowadays. Despite the significant progress in medical care, cancer quality control across the UAE is still lacking, with significant variations in cancer care across the cancer centers. Access to clinical trials is still hampered by a lack of expertise and research infrastructure and a small population, which renders patient accrual for trials a major challenge. Education and training are other areas for improvement that require immediate attention, and, in this review, we try to address these critical aspects for stakeholders to consider better cancer care in the UAE. Early cancer detection and screening are still evolving in the UAE, and a national screening program is lacking. There is also a need to address barriers to screening and to consider less invasive screening methods such as approved blood-based screening, which is likely to be more acceptable to the UAE population. In this review, we also address new topics that have not been addressed previously, including oncology medical tourism, psycho-oncology, onco-fertility, precision oncology, survivorship, oncology nursing, cancer support programs, and the oncology sector’s response to the COVID-19 pandemic, all in the context of the UAE cancer landscape. Finally, we provide recommendations for policymakers, regulators, payers, patient advocacy groups, and the UAE oncology community regarding the delivery and future planning of high-quality cancer care. These recommendations are aligned with the UAE government’s vision to reduce cancer mortality and provide high-quality healthcare for its citizens and residents.https://www.mdpi.com/2039-7283/12/6/101United Arab Emiratesincidencecancerscreeningonco-fertilitypsycho-fertility
spellingShingle Humaid O. Al-Shamsi
The State of Cancer Care in the United Arab Emirates in 2022
Clinics and Practice
United Arab Emirates
incidence
cancer
screening
onco-fertility
psycho-fertility
title The State of Cancer Care in the United Arab Emirates in 2022
title_full The State of Cancer Care in the United Arab Emirates in 2022
title_fullStr The State of Cancer Care in the United Arab Emirates in 2022
title_full_unstemmed The State of Cancer Care in the United Arab Emirates in 2022
title_short The State of Cancer Care in the United Arab Emirates in 2022
title_sort state of cancer care in the united arab emirates in 2022
topic United Arab Emirates
incidence
cancer
screening
onco-fertility
psycho-fertility
url https://www.mdpi.com/2039-7283/12/6/101
work_keys_str_mv AT humaidoalshamsi thestateofcancercareintheunitedarabemiratesin2022
AT humaidoalshamsi stateofcancercareintheunitedarabemiratesin2022